Fresh Equities
ASX:PAR

ASX:PAR

PARADIGM BIOPHARMACEUTICALS LIMITED

4W AVG VOLUME
719.92k
Data provided by Weblink | as of close 2020-01-24
4W AVG TURNOVER
$2.51m

PARADIGM BIOPHARMACEUTICALS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
$50k - 100k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

22 October 2018

Placement

15 April 2019

Placement
Raised
$51.6m
Offer Price
$1.500
Discount
21.05%
Price at Close
$1.900
Market Cap
$266.56m
Re-listed
17-04-2019

Company Overview

Paradigm Biopharmaceuticals Limited (PAR) is an Australian biopharmaceutical company focused on repurposing the drug 'pentosan polysulphate sodium' (PPS) for the treatment of bone marrow edema. Paradigm is targeting addressable markets with the aim to use the shortened development pathway utilising repurposed drugs.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

Level 2/517 Flinders Ln, Melbourne VIC 3000, Australia

Biotechnology
Health Care
Biotech
Osteoarthritis
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors

Fresh Equities does not have PARADIGM BIOPHARMACEUTICALS LIMITED directors data.


Announcements

All
All Time
    Updated Appendix 2A on 15 January 2020

    Issued Capital

    Cleansing Notice on 14 January 2020

    Issued Capital

    Appendix 2A on 14 January 2020

    Issued Capital

  • Cleansing Notice and Appendix 3B on 18 December 2019

    Issued Capital

  • Cleansing Notice and Appendix 3B on 13 December 2019

    Issued Capital

  • Paradigm End of Calendar Year Update on 11 December 2019

    Progress Report

  • Cleansing Notice on 3 December 2019

    Issued Capital

    Appendix 3B on 3 December 2019

    Issued Capital

    Cleansing Notice and Appendix 3B on 25 November 2019

    Issued Capital

    Change of Director's Interest Notice on 19 November 2019

    Shareholder Details

    Load More

News

Loading...